Musculoskeletal Diseases clinical trials at UCLA

2 in progress, 1 open to eligible people

Showing trials for

  • SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization

    open to eligible people ages 40-79

    An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).

    Torrance 5403022, California 5332921 and other locations

  • Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

    Sorry, in progress, not accepting new patients

    AOC 1001-CS2 (MARINA-OLE) is a Phase 2 extension of the AOC 1001-CS1 (MARINA) study to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple-doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) patients

    Los Angeles 5368361, California 5332921 and other locations

Our lead scientists for Musculoskeletal Diseases research studies include .

Last updated: